Best Practices for Managing Blood Pressure in Acute Cerebrovascular Emergencies

Pre-registration for:
Best Practices for Managing Blood Pressure in Acute Cerebrovascular Emergencies

Wednesday October 21, 2026

Seattle Convention Center
Room: 608 & 609
705 Pike Street
Seattle, Washington

Register using the form provided below. Click HERE for additional meeting details.
 
Register using the form provided below. Click HERE for additional meeting details.
+ Add a Registration
Security Check *
* Required fields.
Symposium Poster

Program Overview:

Acute blood pressure (BP) management is neurologic patients is paramount.
Different cerebrovascular emergencies dictate various BP goals. Ischemic strokes
account for >80% of all strokes in the United States and >60% of all strokes
globally; acute ischemic stroke (AIS) is the second leading cause of death
worldwide. There are distinct BP management strategies to be applied
prehospital, after diagnosis but before reperfusion treatment, after intravenous
(IV) thrombolysis, and after endovascular thrombectomy. Neurocritical care
clinicians must be aware of the latest recommendations, and supportive
clinical trial evidence, described in the 2026 American Heart Association
(AHA)/American Stroke Association (ASA) AIS guideline. Acute spontaneous
(nontraumatic) intracerebral hemorrhage (ICH) causes one-third of strokes and
half the deaths and disability due to stroke worldwide. AHA/ASA spontaneous
ICH guidelines indicate that in patients with spontaneous ICH requiring acute
BP lowering, careful titration to ensure continuous smooth and sustained
control of BP, avoiding peaks and large variability in SBP, can be beneficial for
improving functional outcome. The acute management of ICH is critically timesensitive;
current AHA/ASA guidelines state that in patients in whom acute BP
lowering is considered, initiating treatment within 2 hours of ICH onset and
reaching target within 1 hour can be beneficial to reduce the risk of hematoma
and improve functional outcome. Increased BP variability in the acute phases
of cerebrovascular emergences, such as AIS and ICH, has been shown to result
in worsened outcomes. Although several studies have reported this association,
no consensus exists for specific BP variability targets or a consistent, unified
definition of BP variability in AIS or ICH. A consortia has recently developed
a working consensus on defining BP variability, identifying interventions to
mitigate negative outcomes from increased BP variability, and laying the
groundwork for BP variability concepts in the future. In this symposium, experts
will describe best practices for BP management in patients experiencing acute
cerebrovascular emergencies and emerging concepts through state-of-the-art
lectures and a “real-world” case presentation.

Educational Objectives:

Upon completion of this activity, participants should be able to:

  • Identify BP recommendations and supportive evidence from the AHA/ASA Acute Ischemic Stroke (AIS) 2026 guideline
  • Explain findings from landmark BP trials in patients with intracerebral hemorrhage (ICH) and recently published clinical insights
  • Recognize the importance of reducing BP variability in AIS and ICH patients
  • Describe the profiles of, and clinical evidence for antihypertensive agents used for the management of acute cerebrovascular emergencies

Target Audience:

This educational activity is intended for clinicians who manage patients experiencing acute cerebrovascular emergencies

Accreditation and Credit Designation Statements

Voxmedia, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Voxmedia, LLC designates this live activity for a maximum of 1.0 AMA PRA Category Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements. The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Educational Grant:

Voxmedia International gratefully acknowledges the educational grant provided by Chiesi USA, Inc.

Disclosure Information

Voxmedia strives to ensure fair-balance, independence, objectivity, and scientific rigor in all directly or jointly sponsored educational activities. All prospective faculty are required to disclose to Voxmedia all financial relationships for the preceding 24 months (1) with any commercial interest producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients AND (2) with any commercial supporters prior to participating in the planning of an activity or developing content. Only after Voxmedia mitigates all financial relationships may faculty receive approval to participate, and are expected to contribute evidence-based material. Faculty are required to indicate areas of their presentation that are based on professional opinion vs. guidelines, meta-analysis. All information submitted will be peer-reviewed. The intent of this disclosure is not to prevent faculty from participating, but rather to provide learners with information on which they can make their own judgment of commercial bias. Voxmedia will disclose to learners that all relevant financial relationships have been mitigated in either written materials, visually and/or verbally. It remains for the audience to determine whether the speaker’s interests or relationships may influence the presentation. Speakers must make a meaningful disclosure to the audience of their discussions of any unlabeled or investigational use(s) of drugs or devices.

Americans with Disabilities Act:

Voxmedia fully complies with the legal requirements of the ADA and the rules andregulations thereof. If any participant of this activity is in need of accommodation, please call and/or submit in writing to: Voxmedia, 1 Bethany Rd. Bldg 3, Suite 48, Hazlet, NJ 07730. Phone: 973-467-0500.